TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 ViewZacks Investment Research • 05/07/26
TG Therapeutics Reports First Quarter 2026 Financial Results and Raises BRIUMVI Revenue GuidanceGlobeNewsWire • 05/06/26
TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business UpdateGlobeNewsWire • 04/30/26
TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 04/27/26
TG Therapeutics: Flawless Execution And $500 Million Non-Dilutive Capital Bolster OutlookSeeking Alpha • 04/19/26
TGTX Completes Enrollment in Phase III Study on Subcutaneous BriumviZacks Investment Research • 04/16/26
TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVIGlobeNewsWire • 04/15/26
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting DownsideSeeking Alpha • 03/31/26
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 MillionGlobeNewsWire • 03/19/26
This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock DropThe Motley Fool • 03/16/26
Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple SclerosisGlobeNewsWire • 03/09/26
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual MeetingGlobeNewsWire • 03/06/26
Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple SclerosisBusiness Wire • 03/02/26
TG Therapeutics: 'Strong Buy' On BRIUMVI's Massive Growth And Possible ExpansionSeeking Alpha • 02/27/26
TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue GuidanceGlobeNewsWire • 02/26/26
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/23/26
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2025 Financial Results and Business UpdateGlobeNewsWire • 02/23/26
TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple SclerosisGlobeNewsWire • 02/08/26